News & Events

IDWeek 2020

IDWeek 2020

Virtual Event Healix is a proud exhibitor at IDWeekTM 2020! Uniquely focused in infectious disease (ID) and supporting over 300 ID physicians across the country, we are the nation's leader in providing physician office-based infusion services. Focused on patient...

Read More

Hospital Avoidance
Healix Demonstrates Hospital Avoidance with Provision of Outpatient Antimicrobial Therapy (OPAT): A Leader in the Field for Over 30 Years

Healix Demonstrates Hospital Avoidance with Provision of Outpatient Antimicrobial Therapy (OPAT): A Leader in the Field for Over 30 Years

SUGAR LAND, TX – (July 9, 2020) Healix Infusion Therapy, LLC has demonstrated success in achieving hospital avoidance when providing outpatient antimicrobial therapy (OPAT) to patients with serious infections through physician offices. Healix manages over 70...

Read More

Healix Announces First Real-World Study of Immune Globulin Subcutaneous 16.5% (Cutaquig®) Featured in the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting

Healix Announces First Real-World Study of Immune Globulin Subcutaneous 16.5% (Cutaquig®) Featured in the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting

SUGAR LAND, TX – (May 7, 2020) Healix Infusion Therapy is pleased to announce that its collaborative research study regarding Immune Globulin Subcutaneous 16.5% (Cutaquig®) is now accessible in the AAAAI Annual Meeting Virtual Poster Hall. The study by authors...

Read More

/bezlotoxumab-real-world-study-demonstrates-success-in-prevention-of-clostridioides-difficile-infection
Healix Infusion Therapy and Collaborators Publish Real-World Experience of Bezlotoxumab for Prevention of <em>Clostridioides difficile</em> Infection: A Retrospective Multicenter Cohort Study

Healix Infusion Therapy and Collaborators Publish Real-World Experience of Bezlotoxumab for Prevention of Clostridioides difficile Infection: A Retrospective Multicenter Cohort Study

SUGAR LAND, TX – (March 20, 2020) Healix Infusion Therapy, LLC, announced today the publication of a collaborative study in the leading scientific journal, Open Forum Infectious Diseases. This real-world multicenter study demonstrated successful prevention of...

Read More

Thank You Healthcare Heroes!

Thank You Healthcare Heroes!

The team at Healix would like to thank all the healthcare heroes who are on the front lines treating patients during this unprecedented time with the COVID-19 crisis. We know you are faced with new challenges every day, and we are sincerely grateful, now more than...

Read More